# Chlorzoxazone in Hip and Knee Arthroplasty

> **NCT02405104** · PHASE4 · COMPLETED · sponsor: **Northern Orthopaedic Division, Denmark** · enrollment: 400 (actual)

## Conditions studied

- Osteoarthritis of Hip
- Osteoarthritis, Knee

## Interventions

- **DRUG:** chlorzoxazone
- **DRUG:** Placebo
- **PROCEDURE:** THA
- **PROCEDURE:** TKA

## Key facts

- **NCT ID:** NCT02405104
- **Lead sponsor:** Northern Orthopaedic Division, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02405104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02405104, "Chlorzoxazone in Hip and Knee Arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02405104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*